Bifeprunox - Atypical Antipsychotic Drug, No Country

Print

Bifeprunox mesilate is a novel atypical antipsychotic agent under development by Solvay Pharmaceuticals.
 
Next»

Return to Profile




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

For every phase of your drug development